MedPath

To study the effect of Jalaukavcharan and Amoxicillin 500mg and Clavulanic acid 125mg in Nasur with special referance to Acute Dacryocystitis

Phase 2/3
Not yet recruiting
Conditions
Disorder of lacrimal system, unspecified. Ayurveda Condition: NETRAROGAH/AKSHIROGAH,
Registration Number
CTRI/2022/10/046469
Lead Sponsor
Vidarbha Ayurved Mahavidyalaya Amravati
Brief Summary

Randomized clinical trial will be conducted to study the effect of Jalaukavcharan in Puyalasa with special referance to Acute dcryocystitis. Trial will be conducted in our institute. Total 60 patients with inclusive criteria having sign and symptomps of Puyalasa will be selected and will be divided in two groups. One group will be advised Jalaukavcharan and other will be advised Amoxicillin 500mg and Clavulanic acid 125 mg.And result will be compared. Primary outcome will be about Evaluation of Puyalasa and secondary outcome will be about assesssment criteria of effect of Jalaukavcharan. And results will be noted.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1 Patients having classical sign and symptoms of Puyalasa 2 patient will be selected irrespective of sex religion occupation.

Exclusion Criteria

1 Patient with congenital Dacryocystitis 2 Patient with other occular disease 3 Recently operated patients 4 Patients with other systemic disorder like DM HTN.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Uttamupashaya- 75-100%0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day
Alpaupashaya- 25-49%0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day
Anupashaya- less than 25%0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day
Madhyanupashaya- 50-74%0th day | 3rd day | 5th day | 15th day | 30th day | 60th day | 90th day
Secondary Outcome Measures
NameTimeMethod
Remission in symptoms of EpiphoraRemission in redness at medial canthus

Trial Locations

Locations (1)

Vidarbha Aturved Mahavidyalaya and Hospital Amravati

🇮🇳

Amravati, MAHARASHTRA, India

Vidarbha Aturved Mahavidyalaya and Hospital Amravati
🇮🇳Amravati, MAHARASHTRA, India
Swati Baliram Bhagile
Principal investigator
7030084201
swatibhagile9936@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.